An adaptive clinical trial on patients with non variceal upper gastrointestinal bleed with the help of endoscopy
DOI:
https://doi.org/10.18203/2349-3933.ijam20200654Keywords:
Anti-fibrinolytic agent, Proton pump inhibitor, Somatostatin, Upper gastrointestinal bleedAbstract
Background: Acute upper gastrointestinal hemorrhage (UGIH) is a common condition worldwide frequently leads to hospital admission also has a significant associated morbidity and mortality, especially in the elderly. A systematic diagnostic and definite therapeutic approach is essential to establish a diagnosis, relevant to specific investigations for appropriate treatment in tertiary medical care center.
Methods: A comparative trial was done on n=109 cases with an objective to find out the different causes of UGI bleed in population, to assess the requirement of blood transfusion in patients with massive GI Bleed and to compare the treatment outcome of Proton pump inhibitors over Tranexamic acid and Octreotide in non-variceal UGI bleed. The cases were assigned to three different groups by lottery system. Proton pump inhibitors (Omeprazole), Somatostatin (Octreotide), Anti-fibrinolytic (Tranexamic acid), outcome was assessed after complete treatment and follow up.
Results: Out of 150 cases, 109 were diagnosed with non-variceal GI bleed, 35 cases were treated with Omeprazole out of which 11.42% cases received blood transfusion, and 4 had history of re bleeding, Mean Duration of stay in hospital was 4.4±1.75, when compared to the other two group the duration of hospitalization was least as the P value was <0.0001.
Conclusions: In this study it was demonstrated the use of PPI in case of Non-Variceal Bleeding significantly reduces the need of blood transfusion. Even it reduces the cases of re bleeding and duration of hospital stay.
References
Rockall TA, Logan RF, Devlin HB, Northfield TC. Selection of patients for early discharge or outpatient care after acute upper gastrointestinal haemorrhage. National audit of acute upper gastrointestinal haemorrhage. Lancet. 1996;347:1138-40.
Ghosh S, Watts D, Kinnear M. Management of gastrointestinal haemorrhage. Postgrad Med J. 2002;78:4-14.
British Society of Gastroenterology Endoscopy Committee. Non-variceal upper gastrointestinal haemorrhage: guidelines. Gut. 2002 Oct; 51 Suppl 4:iv1-6.
Pongprasobchai S, Nimitvilai S, Chasawat J, Manatsathit S. Upper gastrointestinal bleeding etiology score for predicting variceal and non-variceal bleeding. World J Gastroenterol: WJG. 2009 Mar 7;15(9):1099-104.
Anand D, GuptaR, Dhar M, Ahuja V. Clinical and endoscopic profile of patients with upper gastrointestinal bleeding at tertiary care centre of North India. J Dig Endosc. 2014;5:139-43.
Rathi P, Abraham P, Jakareddy R, Pai N. Spectrum of upper gastrointestinal bleeding in Western India. Indian J Gasteroenterol. 2001;20 suppl 2:A37.
Rodrigues G, Shenoy R, Rao A. Profile of non variceal upper gastrointestinal: Bleeding in a tertiary referral hospital. Int J Surg. 2004;5:17-22.
Wang J, Cui Y, Wang J, Chen B, He Y, Chen M. Clinical epidemiological characteristics and change trend of upper gastrointestinal bleeding over the past 15 years. Zhonghuawei Chang Wai Ke Za Zhi. 2017 Apr 25;20(4):425-431.
Toosi SM, Vahed AR, Maleki I, Bari Z. Comparison of Oral versus Intravenous Proton Pump Inhibitors in Preventing Re-bleeding from Peptic Ulcer after Successful Endoscopic Therapy. Middle East J Digestive Dis. 2018 Oct;10(4):236.
Choi CW, Kang DH, Kim HW, Park SB, Park KT, Kim GH, et al. Somatostatin adjunctive therapy for non-variceal upper gastrointestinal rebleeding after endoscopic therapy. World J Gastroenterol. 2011 Aug 7;17(29):3441-7.
Gluud LL, Klingenberg SL, Langholz E. Tranexamic acid for upper gastrointestinal bleeding. Cochrane Database Syst Rev. 2012;1:CD006640.